BWXTNYSEEngines & TurbinesUS GAAP · USD

BWX Technologies, Inc.

BWX Technologies, Inc. is a U.S.-based specialty manufacturer and services provider built around nuclear technologies with roots going back more than a century. The company designs and manufactures precision naval nuclear components, reactors, and nuclear fuel for the U.S. Government, while also serving commercial nuclear power customers with heavy components, fuel, lifecycle services, and refurbishment support. It additionally operates in environmental remediation, special nuclear materials processing, and advanced nuclear applications such as medical radioisotopes and radiopharmaceuticals. BWXT’s business is organized around two segments, Government Operations and Commercial Operations, and much of its revenue comes from large, long-duration contracts and major projects. Recent acquisitions, including Kinectrics and Aerojet Ordnance Tennessee, have expanded its capabilities in nuclear lifecycle services, advanced materials, and isotope production.

Revenue3,198m USD
+328.6 %y/y
Operating profit (EBIT)404m USD
+6.3 %y/y
EBIT margin12.6%
−38.4 ppy/y
Net income329m USD
+16.7 %y/y
Free cash flow295m USD
+15.9 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

01,0002,0003,0004,000m USD2020: 2,124 m USD2020: EBIT 89 m USD20202021: 592 m USD2021: EBIT 346 m USD20212022: 624 m USD2022: EBIT 102 m USD20222023: 726 m USD2023: EBIT 383 m USD20232024: 746 m USD2024: EBIT 381 m USD20242025: 3,198 m USD2025: EBIT 404 m USD20253,198404
RevenueOperating profit (EBIT)

Business

Share of revenue
Government nuclear systems68 %

Naval nuclear components, reactors, nuclear fuel, and related U.S. Government programs and facility operations.

Commercial nuclear equipment20 %

Heavy nuclear components, steam generators, pressure vessels, fuel systems, and engineering services for nuclear utilities.

Lifecycle and site services7 %

Maintenance, refurbishment, outage support, plant life extension, and environmental remediation services.

Medical isotopes and radiopharmaceuticals3 %

Critical radioisotopes, isotope supply, and radiopharmaceutical-related products for diagnostic and therapeutic use.

Advanced materials and other technologies2 %

Special materials, advanced nuclear technologies, and adjacent products for commercial, military, and space applications.

Customers

BWXT sells primarily to the U.S. Government, especially agencies and programs tied to naval nuclear propulsion, defense, and government-owned nuclear facilities. It also serves nuclear power utilities, particularly in Canada and other markets where refurbishment, plant life extension, and fuel handling projects drive demand. A smaller but strategically important customer base includes isotope processors, radiopharmaceutical manufacturers, and healthcare-related users of medical radioisotopes. The company’s commercial work is often tied to outage timing, capital spending cycles, and long project lead times, which makes customer demand lumpy and project-driven. Because many contracts are large and specialized, customers buy BWXT for technical qualification, regulatory capability, and sole-source or hard-to-replace nuclear expertise.

U.S. Government / defense

Buys naval nuclear components, reactors, nuclear fuel, and facility operations support for defense and strategic programs.

Nuclear power utilities

Buys heavy components, fuel handling systems, engineering, maintenance, and refurbishment services for operating reactors.

Government site operations and remediation customers

Buys management, operation, decontamination, and decommissioning services for government-owned nuclear sites.

Medical isotope and radiopharmaceutical customers

Buys radioisotopes and related products for diagnostic imaging and therapeutic applications.

Industrial and advanced materials customers

Buys special materials and advanced nuclear-adjacent products for commercial, military, and space uses.

Strategy

BWXT’s strategy centers on deepening its position in mission-critical nuclear markets where technical qualification, regulatory barriers, and long contract durations support customer stickiness. The company is expanding through strategic investments and acquisitions to broaden its nuclear lifecycle, materials, and isotope capabilities, as shown by the purchases of Kinectrics and Aerojet Ordnance Tennessee. It is also building out adjacent growth platforms in medical isotopes, radiopharmaceuticals, advanced nuclear technologies, and special materials for commercial, military, and space applications. At the same time, BWXT continues to rely on large government and utility contracts, so execution quality, backlog conversion, and project performance remain central to the strategy. The overall direction is to complement the legacy defense and commercial nuclear base with higher-value services and technologies that can scale across the nuclear ecosystem.

Acquire and integrate complementary nuclear businessesMedium term

Acquisitions broaden the product set, add technical depth, and expand addressable markets without starting from scratch.

Grow medical isotope and radiopharmaceutical offeringsMedium term

These products diversify revenue beyond defense and utility contracts and can support higher-value specialty demand.

Protect and extend the government nuclear franchiseShort term

The U.S. Government remains the largest customer and a core source of scale, credibility, and backlog.

Geography

Q1/2026

BWXT is headquartered in the United States and derives the majority of its revenue from U.S. Government programs, so the U.S. is the company’s dominant market and operating base. The Commercial Operations segment has meaningful exposure to Canada, where nuclear fuel, fuel handling, refurbishment, and lifecycle services are especially important. The company also serves global nuclear power and radiopharmaceutical markets, but the business remains concentrated in North America. BWXT operates large manufacturing and licensed nuclear facilities in both the U.S. and Canada, which makes regulatory compliance, security, and site continuity central to its geography profile. Because a large share of revenue is tied to government spending and Canadian nuclear utility activity, changes in those markets can materially affect performance.

United States72 %
Canada28 %

Share of the revenue the company reports by geography.

Risks

BWXT faces concentration risk because a large share of revenue depends on the U.S. Government and defense-related spending, so budget shifts or program changes could affect results. Its business is also exposed to execution risk on large, complex, fixed-scope or long-duration contracts, where cost overruns, schedule delays, or estimate revisions can move earnings materially. Nuclear manufacturing and site operations carry elevated safety, security, cyber, and regulatory risk, and any incident could damage reputation, interrupt operations, or trigger liability. The company’s commercial business is cyclical and depends on outage timing, refurbishment spending, and nuclear utility capital budgets, which can create quarter-to-quarter volatility. In addition, facilities in the U.S. and Canada are exposed to severe weather and natural disasters, and insurance may not fully offset the cost of disruptions.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →U.S. Government budget and program concentration1Contract estimate and project execution risk2Cybersecurity and physical security threats3Severe weather and natural disasters4Commercial nuclear cycle volatility5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. U.S. Government budget and program concentrationImpact: HighLikelihood: Medium

    Government Operations is largely driven by defense spending and national security priorities, so funding changes can affect revenue and cash flow.

    Exposure: Largest customer concentration

  2. Contract estimate and project execution riskImpact: HighLikelihood: Medium

    Revenue is recognized over time using cost-to-cost estimates, so changes in labor, materials, or scope can create catch-up adjustments and margin swings.

    Exposure: Large long-duration projects

  3. Cybersecurity and physical security threatsImpact: HighLikelihood: Medium

    The company operates sensitive nuclear facilities and handles proprietary and government-related information, making security breaches potentially disruptive and reputationally damaging.

    Exposure: Manufacturing sites and managed facilities

  4. Severe weather and natural disastersImpact: MediumLikelihood: Low

    Large U.S. and Canadian facilities can be interrupted by storms or other events, causing downtime and recovery costs.

    Exposure: Licensed nuclear manufacturing and fuel facilities

  5. Commercial nuclear cycle volatilityImpact: MediumLikelihood: Low

    Utility spending depends on outage timing, refurbishment cycles, and capital budgets, which can shift revenue between periods.

    Exposure: Canadian and global commercial nuclear markets

Accounting

Judgemental items
Over-time contract revenue recognition

Most revenue is recognized based on progress toward completion, so estimate changes directly affect reported revenue and operating income.

Impact: Can create material quarterly catch-up adjustments

Loss contract accruals

If estimated total costs exceed contract value, the expected loss is recognized immediately.

Impact: Can cause sudden margin deterioration on specific projects

Acquisition accounting and goodwill

Recent acquisitions add intangible assets and goodwill that require ongoing impairment assessment.

Impact: Potential non-cash charges if integration or market assumptions weaken

Joint venture accounting

Several government contracts are executed through joint ventures and may be accounted for under the equity method.

Impact: Affects how operating exposure and earnings are presented

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

BWX Technologies, Inc. (BWXT) Revenue, Earnings & Financials 2025 – Clarifo